8. B
See the sentence in para.2 under the subtitle “Hypnotic effects” (The product information for prescribers advises that psychiatric adverse effects, including hallucinations, sleepwalking and nightmares, are more likely in the elderly, and treatment should be stopped if they occur.) and the sentence in para.3 under the subtitle “Tried and tested” (Doctors “not the product information” stress that the medication should be taken just before going to bed.)
9. B
See para.5 under the subtitle “Tried and tested”: Sanofi-Aventis spokesperson Melissa Feltmann „ says that “the safety profile [of zolpidem] is well established”.
10. 674,500 (times)
See para.3 from the beginning: Various forms of the drug, made by French pharmaceutical giant Sanofi-Aventis, were prescribed 674,500 times in 2005 in the UK.
11. (a) benzodiazepine-like (hypnotic)
See para.1 under the subtitle “Hypnotic effects”: The drug is a benzodiazepine-like hypnotic (类苯二氮催眠药)that promotes deep sleep by
interacting with brain receptors for a chemical called gamma-aminobutyric acid.
12. risky consequences
See para.3 under the subtitle “Hypnotic effects”: Patient advocacy groups „ stress that strange sleepwalking and sleep-driving behaviours can have risky consequences.
13. Food & Drug (Administration)
See para.4 under the subtitle “Tried and tested”: The US Food & Drug Administration says it is continuing to "actively investigate" and collect information about cases linking zolpidem to unusual side effects.